Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrial Neoplasms | 5 | 2022 | 1357 | 0.470 |
Why?
|
Brachytherapy | 4 | 2022 | 1238 | 0.380 |
Why?
|
Therapeutic Human Experimentation | 1 | 2009 | 43 | 0.340 |
Why?
|
Leukemia, Plasma Cell | 1 | 2009 | 46 | 0.330 |
Why?
|
Pulmonary Eosinophilia | 1 | 2009 | 78 | 0.330 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2007 | 0.320 |
Why?
|
Ethics, Research | 1 | 2009 | 176 | 0.310 |
Why?
|
Pancreatic Neoplasms | 2 | 2017 | 5351 | 0.290 |
Why?
|
Thalidomide | 2 | 2009 | 884 | 0.280 |
Why?
|
Diffusion of Innovation | 1 | 2009 | 730 | 0.240 |
Why?
|
Informed Consent | 1 | 2009 | 1005 | 0.210 |
Why?
|
Stomach Neoplasms | 1 | 2013 | 1423 | 0.210 |
Why?
|
Esophageal Neoplasms | 1 | 2013 | 1648 | 0.210 |
Why?
|
Vaginal Neoplasms | 1 | 2021 | 104 | 0.180 |
Why?
|
Emergency Medicine | 1 | 2009 | 1196 | 0.180 |
Why?
|
General Surgery | 1 | 2009 | 1678 | 0.150 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 429 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11712 | 0.140 |
Why?
|
Carcinoma, Endometrioid | 1 | 2019 | 276 | 0.140 |
Why?
|
Cisplatin | 1 | 2021 | 1644 | 0.120 |
Why?
|
Ribosomal Proteins | 2 | 2008 | 363 | 0.120 |
Why?
|
Biomedical Research | 1 | 2009 | 3426 | 0.110 |
Why?
|
Colon, Sigmoid | 1 | 2014 | 124 | 0.110 |
Why?
|
STAT Transcription Factors | 1 | 2014 | 188 | 0.110 |
Why?
|
Janus Kinases | 1 | 2014 | 250 | 0.110 |
Why?
|
Organs at Risk | 1 | 2014 | 358 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2022 | 9276 | 0.090 |
Why?
|
Erythroid Precursor Cells | 2 | 2008 | 211 | 0.090 |
Why?
|
Erythroid Cells | 2 | 2008 | 235 | 0.090 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 2008 | 385 | 0.080 |
Why?
|
Rectum | 1 | 2014 | 895 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 2014 | 533 | 0.080 |
Why?
|
Anemia, Diamond-Blackfan | 2 | 2008 | 136 | 0.070 |
Why?
|
Myeloproliferative Disorders | 1 | 2014 | 609 | 0.070 |
Why?
|
Urinary Bladder | 1 | 2014 | 1166 | 0.070 |
Why?
|
RNA Interference | 2 | 2008 | 2846 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6828 | 0.070 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13630 | 0.070 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11152 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2021 | 1791 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2008 | 11481 | 0.060 |
Why?
|
Aged | 9 | 2021 | 169152 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8555 | 0.060 |
Why?
|
Erythropoiesis | 1 | 2008 | 682 | 0.060 |
Why?
|
Megakaryocytes | 1 | 2008 | 565 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2009 | 1548 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58995 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2008 | 2381 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3529 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1354 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 3 | 2008 | 3387 | 0.050 |
Why?
|
Female | 11 | 2022 | 391270 | 0.050 |
Why?
|
Nucleic Acids | 1 | 2004 | 188 | 0.050 |
Why?
|
Middle Aged | 8 | 2021 | 220352 | 0.050 |
Why?
|
Radiotherapy Dosage | 2 | 2020 | 2897 | 0.050 |
Why?
|
Humans | 18 | 2022 | 760621 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2008 | 11903 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1885 | 0.040 |
Why?
|
Carcinosarcoma | 1 | 2020 | 104 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 65017 | 0.040 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2020 | 217 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2021 | 877 | 0.040 |
Why?
|
Genomics | 1 | 2014 | 5794 | 0.040 |
Why?
|
Myelodysplastic Syndromes | 1 | 2008 | 1394 | 0.040 |
Why?
|
Dexamethasone | 1 | 2005 | 1927 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 10182 | 0.040 |
Why?
|
Biosensing Techniques | 1 | 2004 | 677 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2022 | 80372 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3775 | 0.030 |
Why?
|
Adult | 7 | 2021 | 219994 | 0.030 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 479 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2021 | 972 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2005 | 2050 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2022 | 1268 | 0.030 |
Why?
|
K562 Cells | 2 | 2008 | 640 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2008 | 18957 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2008 | 4742 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4550 | 0.030 |
Why?
|
Young Adult | 2 | 2021 | 58741 | 0.030 |
Why?
|
Antigens, CD34 | 2 | 2008 | 653 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7593 | 0.030 |
Why?
|
Calreticulin | 1 | 2014 | 115 | 0.030 |
Why?
|
Chromosome Deletion | 2 | 2008 | 1387 | 0.030 |
Why?
|
Mastectomy | 1 | 2021 | 1832 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29658 | 0.030 |
Why?
|
MicroRNAs | 1 | 2008 | 3790 | 0.020 |
Why?
|
Erythropoietin | 2 | 2008 | 720 | 0.020 |
Why?
|
Male | 4 | 2017 | 359744 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23376 | 0.020 |
Why?
|
Janus Kinase 2 | 1 | 2014 | 542 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20509 | 0.020 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9411 | 0.020 |
Why?
|
Homozygote | 1 | 2014 | 1788 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8552 | 0.020 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2008 | 52 | 0.020 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2008 | 57 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2008 | 79 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2601 | 0.020 |
Why?
|
Integrin beta3 | 1 | 2008 | 121 | 0.020 |
Why?
|
Cell Lineage | 2 | 2008 | 2533 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2698 | 0.020 |
Why?
|
RNA, Ribosomal | 1 | 2008 | 226 | 0.020 |
Why?
|
RNA Precursors | 1 | 2008 | 212 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2008 | 226 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12808 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17790 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2008 | 629 | 0.020 |
Why?
|
Stem Cell Factor | 1 | 2005 | 196 | 0.010 |
Why?
|
Ribosomes | 1 | 2008 | 501 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2828 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2008 | 1529 | 0.010 |
Why?
|
Interleukin-3 | 1 | 2005 | 425 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2005 | 869 | 0.010 |
Why?
|
Luciferases | 1 | 2005 | 716 | 0.010 |
Why?
|
Retroviridae | 1 | 2005 | 850 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2004 | 1304 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2608 | 0.010 |
Why?
|
United States | 1 | 2009 | 72461 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3280 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2414 | 0.010 |
Why?
|
Models, Biological | 2 | 2008 | 9467 | 0.010 |
Why?
|
Phenotype | 2 | 2008 | 16546 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4573 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2913 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41335 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5039 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54303 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22053 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4122 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2005 | 2145 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 5870 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12446 | 0.010 |
Why?
|
Stem Cells | 1 | 2005 | 3523 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15289 | 0.010 |
Why?
|
Mice | 2 | 2008 | 81208 | 0.010 |
Why?
|
Cell Line | 1 | 2005 | 15620 | 0.010 |
Why?
|
Animals | 3 | 2008 | 167963 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12766 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22023 | 0.010 |
Why?
|
Mutation | 1 | 2014 | 29932 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10446 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14660 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40165 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_